Our partner is a biopharmaceutical company specializing in the discovery and development of antibody-drug conjugate (ADC) therapies to treat patients fighting cancer. Leveraging decades of industry learnings, they have developed proprietary and highly differentiated ADC platforms and expertise to rapidly design and test novel ADCs and identify those with optimal efficacy, safety, and tolerability.

This critical hire guided the clinical operations strategy for our partner’s drug development programs. They led and mentored colleagues with less experience and ensured processes were optimized for maximum efficiency and GCP compliance. They worked closely with the Clinical Development team supporting the Vice President in the creation and execution of global clinical development plans and studies and helped represent high value programs to Senior Management.